Our study results sustain the conclusions that OXA can significantly improve neurofunctional outcomes and mitigate brain edema after ICH, possibly through the mechanism of alleviating neuroinflammation via OXR2/CaMKKβ/AMPK pathway. The gene discussed is HCRTR2; the disease is brain edema.